Back to top
more

Boston Scientific (BSX)

(Delayed Data from NYSE)

$74.45 USD

74.45
4,474,605

+0.96 (1.31%)

Updated May 15, 2024 04:00 PM ET

After-Market: $74.43 -0.02 (-0.03%) 7:20 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth C Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 42% (145 out of 250)

Industry: Medical - Products

Better trading starts here.

Zacks News

Headquartered in Natick, MA and founded in 1979, Boston Scientific Corporation manufactures medical devices and products used in various interventional medical specialties worldwide. The company has adopted the organic as well as inorganic routes for success. Boston Scientific currently has 3 global reportable segments viz. Cardiovascular (39.6% of total revenue in 2019; up 10% organically from 2018), Rhythm and Neuro (28.1%; up 1%) and MedSurg (30.2%; up 10.6%).

Company News For Feb 7, 2019

Companies In The News are: CPRI,BSX,GM,SNAP

Bright Near-Term Outlook for Medical Instruments Industry

Growing medical awareness and economic prosperity have been enhancing the uptake of medical instruments in the emerging economies.

Boston Scientific (BSX) Beats on Q4 Earnings, Margins Dip

Boston Scientific (BSX) is leaving no stone unturned to strengthen its core businesses and invest in global markets, which accounted for the uptick in sales across all geographies.

Boston Scientific (BSX) Q4 Earnings and Revenues Beat Estimates

Boston Scientific (BSX) delivered earnings and revenue surprises of 5.41% and 0.11%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?

Can Boston Scientific (BSX) Q4 Earnings Fuel Overall Growth?

We are hopeful that Boston Scientific (BSX) will report a strong IC business globally in Q4, backed by an innovative portfolio and robust commercial teams.

Boston Scientific (BSX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Boston Scientific (BSX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

VREX vs. BSX: Which Stock Is the Better Value Option?

VREX vs. BSX: Which Stock Is the Better Value Option?

The Zacks Analyst Blog Highlights: Boston Scientific, Southern, BNY, Schlumberger and Southwest

The Zacks Analyst Blog Highlights: Boston Scientific, Southern, BNY, Schlumberger and Southwest

Mark Vickery headshot

Top Analyst Reports for Boston Scientific, Southern Company & BNY Mellon

Today's Research Daily features new research reports on 16 major stocks, including Boston Scientific (BSX), Southern Company (SO) and BNY Mellon (BK).

Boston Scientific Gains on Impressive Preliminary Q4 Results

Boston Scientific's (BSX) solid top line is expected to be backed by growth across all segments and geographical regions in Q4.

Boston Scientific (BSX) to Buy Residual Shares of Millipede

Boston Scientific's (BSX) buyout of the leftover stake in Millipede will integrate the latter's IRIS Transcatheter Annuloplasty Ring System in the Structural Heart portfolio of the former.

HRC or BSX: Which Is the Better Value Stock Right Now?

HRC vs. BSX: Which Stock Is the Better Value Option?

Boston Scientific (BSX) Outpaces Stock Market Gains: What You Should Know

Boston Scientific (BSX) closed at $37.67 in the latest trading session, marking a +1.7% move from the prior day.

HRC or BSX: Which Is the Better Value Stock Right Now?

HRC vs. BSX: Which Stock Is the Better Value Option?

Boston Scientific (BSX) Outpaces Stock Market Gains: What You Should Know

Boston Scientific (BSX) closed at $34.60 in the latest trading session, marking a +1.62% move from the prior day.

Boston Scientific's (BSX) $4.2B Buyout to Augment PI Business

Boston Scientific (BSX) continues to expand on the back of its inorganic growth strategy. The latest takeover is expected to boost the PI business.

Edwards Lifesciences' CE Mark for SAPIEN 3 Boosts THVT Arm

Latest CE Mark receipt is expected to fortify Edwards Lifesciences' (EW) position in Europe.

Boston Scientific (BSX) Gains But Lags Market: What You Should Know

In the latest trading session, Boston Scientific (BSX) closed at $36.48, marking a +0.75% move from the previous day.

Boston Scientific (BSX) Gains As Market Dips: What You Should Know

In the latest trading session, Boston Scientific (BSX) closed at $38.60, marking a +0.42% move from the previous day.

HRC vs. BSX: Which Stock Is the Better Value Option?

HRC vs. BSX: Which Stock Is the Better Value Option?

Q3 Earnings Mixed

Q3 Earnings Mixed

Boston Scientific (BSX) Beats on Q3 Earnings, Misses Revenues

Boston Scientific (BSX) registers steady growth across all business lines and geographies in Q3.

Boston Scientific (BSX) Surpasses Q3 Earnings Estimates

Boston Scientific (BSX) delivered earnings and revenue surprises of 2.94% and -0.58%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

Medical Products Q3 Earnings on Oct 24: BSX, ALGN & More

Long-term potential of the Medical Products industry appears promising at the moment amid certain short-term geopolitical insecurities.

Should You Buy Boston Scientific (BSX) Ahead of Earnings?

Boston Scientific (BSX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.